Tweenvest Stocks

Thalys Medical Technology Group Corporation (SHSE: 603716)

Health Care · Biotechnology · CN

CN¥15.84

-8.70% today · -54.3% 1Y

Thalys Medical Technology Group Corporation (SHSE: 603716) operates in the Biotechnology industry within the Health Care sector. The company is valued at $504.50M and employs 1,045 people.

Over the last twelve months the share price has lost 54.3%, trading between 12.92 and 38.12.

Tweenvest scores Thalys Medical Technology Group Corporation across four factors: quality 47/100, value 50/100, growth 0/100. Its strongest factor is value.

603716 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$504.50M
Revenue (TTM)
$140.82M
P/E
EPS
-1.04
Dividend yield
Beta (5Y)
0.32
52-week high
CN¥38.12
52-week low
CN¥12.92
Avg volume (3M)
Shares outstanding
214.11M
Employees
1,045
Next earnings

About Thalys Medical Technology Group Corporation

Thalys Medical Technology Group Inc. is a Chinese enterprise that specializes in providing intensive medical business and operational services. The company, established in 2004, is headquartered in Wuhan, China. It previously operated under the name Thalys Medical Technology Inc. before officially adopting its current designation in September 2020.

ISIN
CNE1000030C3
Founded
2004
Listed since
Oct 31, 2016
Exchange
Shanghai Stock Exchange
Currency
CNY
CompanyMarket capPriceDay
AbbVie Inc.NYSE: ABBV$468.22B$264.96+1.20%
Amgen Inc.NasdaqGS: AMGN$237.52B$439.33+1.29%
Gilead Sciences, Inc.NasdaqGS: GILD$181.18B$146.12+1.86%
Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX$138.91B$548.05+1.44%
Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN$83.28B$834.04+0.90%
argenx SEENXTBR: ARGX$65.85B902.00+1.90%
Moderna, Inc.NasdaqGS: MRNA$57.92B$145.13+0.04%
CSL LimitedASX: CSL$57.77BAU$168.30-1.69%

Browse every Biotechnology company →

Figures last refreshed Aug 18, 2026.